tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

ACLX Stock Latest News

Arcellx downgraded to Neutral from Buy at Rothschild & Co Redburn
The FlyArcellx downgraded to Neutral from Buy at Rothschild & Co Redburn
1d ago
ACLX
Arcellx: Differentiated D-Domain BCMA CAR-T Profile and Safety Advantages Underpin Buy Rating and 58% Upside Potential
PremiumRatings
Arcellx: Differentiated D-Domain BCMA CAR-T Profile and Safety Advantages Underpin Buy Rating and 58% Upside Potential
8d ago
ACLX
Positioning Arcellx for a Pivotal 2026: Anito-cel’s Differentiated Safety, Best-in-Class CAR T Launch Potential, and Undervalued Entry Point
PremiumRatings
Positioning Arcellx for a Pivotal 2026: Anito-cel’s Differentiated Safety, Best-in-Class CAR T Launch Potential, and Undervalued Entry Point
1M ago
ACLX
Arcellx assumed with a Buy at UBS
PremiumThe Fly
Arcellx assumed with a Buy at UBS
1M ago
ACLX
3 ‘Strong Buy’ Stocks to Buy Today,12/23/2025, According to Top Analysts
PremiumMarket News
3 ‘Strong Buy’ Stocks to Buy Today,12/23/2025, According to Top Analysts
2M ago
ACLX
CGON
Midday Fly By: Ellison backstops Paramount bid for Warner Bros.
PremiumThe FlyMidday Fly By: Ellison backstops Paramount bid for Warner Bros.
2M ago
LW
AMD
Arcellx initiated, Cummins upgraded: Wall Street’s top analyst calls
Premium
The Fly
Arcellx initiated, Cummins upgraded: Wall Street’s top analyst calls
2M ago
CMI
SEE
3 ‘Strong Buy’ Stocks to Buy Today,12/22/2025, According to Top Analysts
Premium
Market News
3 ‘Strong Buy’ Stocks to Buy Today,12/22/2025, According to Top Analysts
2M ago
ACLX
AMZN
Wells starts Arcellx with Overweight on multiple myeloma potential
PremiumThe Fly
Wells starts Arcellx with Overweight on multiple myeloma potential
2M ago
ACLX
Arcellx initiated with an Overweight at Wells Fargo
PremiumThe Fly
Arcellx initiated with an Overweight at Wells Fargo
2M ago
ACLX
Positive Outlook for Arcellx Inc: Buy Rating Backed by Strategic Positioning and Promising CAR T-cell Therapy
PremiumRatings
Positive Outlook for Arcellx Inc: Buy Rating Backed by Strategic Positioning and Promising CAR T-cell Therapy
2M ago
ACLX
Arcellx Reports Promising Phase 2 Study Results
PremiumCompany Announcements
Arcellx Reports Promising Phase 2 Study Results
2M ago
8K
ACLX
Promising Clinical Data and Favorable Safety Profile Drive Buy Rating for Arcellx Inc
PremiumRatingsPromising Clinical Data and Favorable Safety Profile Drive Buy Rating for Arcellx Inc
2M ago
ACLX
Arcellx Inc’s Promising Future: Buy Rating Backed by Strong Efficacy, Safety, and Strategic Partnerships
Premium
Ratings
Arcellx Inc’s Promising Future: Buy Rating Backed by Strong Efficacy, Safety, and Strategic Partnerships
2M ago
ACLX
Arcellx Inc’s Anito-cel: Promising CAR-T Therapy with Superior Safety Profile and Market Readiness
Premium
Ratings
Arcellx Inc’s Anito-cel: Promising CAR-T Therapy with Superior Safety Profile and Market Readiness
2M ago
ACLX
Arcellx Inc’s Promising iMMagine-1 Study and Strategic Plans Justify Buy Rating and $112 Price Target
PremiumRatings
Arcellx Inc’s Promising iMMagine-1 Study and Strategic Plans Justify Buy Rating and $112 Price Target
2M ago
ACLX
Optimistic Buy Rating for Arcellx Inc: Promising Anito-cel Therapy and Strategic Advancements
PremiumRatings
Optimistic Buy Rating for Arcellx Inc: Promising Anito-cel Therapy and Strategic Advancements
2M ago
ACLX
Arcellx announces new data for its iMMagine-1 study in patients with RRMM
PremiumThe Fly
Arcellx announces new data for its iMMagine-1 study in patients with RRMM
2M ago
ACLX
GILD
Gilead’s Kite announces new data for iMMagine-1 Study at ASH 2025
PremiumThe Fly
Gilead’s Kite announces new data for iMMagine-1 Study at ASH 2025
2M ago
ACLX
GILD
Arcellx Inc’s Anito-cel: A Promising CAR-T Therapy with Strong Market Positioning and Growth Potential
PremiumRatingsArcellx Inc’s Anito-cel: A Promising CAR-T Therapy with Strong Market Positioning and Growth Potential
3M ago
ACLX
Promising Outlook for Arcellx Inc’s Anito-cel Therapy in Multiple Myeloma Treatment
Premium
Ratings
Promising Outlook for Arcellx Inc’s Anito-cel Therapy in Multiple Myeloma Treatment
3M ago
ACLX
Kelonia data too early to read to Gilead, Arcellx’s anito-cel, says BMO Capital
Premium
The Fly
Kelonia data too early to read to Gilead, Arcellx’s anito-cel, says BMO Capital
3M ago
ACLX
GILD

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >